Topical Drug Delivery to the Posterior Segment of the Eye: Addressing the Challenge of Preclinical to Clinical Translation

Topical delivery of therapeutics to the posterior segment of the eye remains the “holy grail” of ocular drug delivery. As an example, anti–vascular endothelial growth factor biologics, such as ranibizumab, aflibercept, and bevacizumab, are delivered by intravitreal injection to treat neovascular age...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, Gerard A., Lutz, David, Shen, Jie, Yuan, Xiaoda, Shen, Hong, Cunningham, James, Rivers, Hongwen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Expert Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208585/
https://www.ncbi.nlm.nih.gov/pubmed/30374744
http://dx.doi.org/10.1007/s11095-018-2519-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208585/
https://www.ncbi.nlm.nih.gov/pubmed/30374744
http://dx.doi.org/10.1007/s11095-018-2519-x

Ejemplares similares